Abstract:Technology of production of single-domain antibodies (NANOBODY® molecules, also referred to as nanoantibodies, nAb, or molecules based on other stable protein structures) and their derivatives to solve current problems in biomedicine is becoming increasingly popular. Indeed, the format of one small, highly soluble protein with a stable structure, fully functional in terms of specific recognition, is very convenient as a module for creating multivalent, bi-/oligo-specific genetically engineered targeting molecules and structures. Production of nAb in periplasm of E. coli bacterium is a very convenient and fairly universal way to obtain analytical quantities of nAb for the initial study of the properties of these molecules and selection of the most promising nAb variants. The situation is more complicated with production of bi- and multivalent derivatives of the initially selected nAbs under the same conditions. In this work, extended linker sequences (52 and 86 aa) between the antigen-recognition modules in the cloned expression constructs were developed and applied in order to increase efficiency of production of bispecific nanoantibodies (bsNB) in the periplasm of E. coli bacteria. Three variants of model bsNBs described in this study were produced in the periplasm of bacteria and isolated in soluble form with preservation of functionality of all the protein domains. If earlier our attempts to produce bsNB in the periplasm with traditional linkers no longer than 30 aa were unsuccessful, the extended linkers used here provided a significantly more efficient production of bsNB, comparable in efficiency to the traditional production of original monomeric nAbs. The use of sufficiently long linkers could presumably be useful for increasing efficiency of production of other bsNBs and similar molecules in the periplasm of E. coli bacteria.

Effects of interlinker sequences on the biological properties of bispecific single-chain antibodies

Molecular Modeling and Affinity Determination of Scfv Antibody: Proper Linker Peptide Enhances Its Activity

Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv

Design and assembly of anti-CD16 ScFv antibody with two different linker peptides.

Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds

Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody

A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain

Vector design for enhancing expression level and assembly of knob-into-hole based FabscFv-Fc bispecific antibodies in CHO cells

Effects of molecule hydrophobicity and structural flexibility of appended bispecific antibody on Protein A chromatography

Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies

A New Format of Bispecific Antibody: Highly Efficient Heterodimerization, Expression and Tumor Cell Lysis.

Characterization of light chain c-terminal extension sequence variant in one bispecific antibody

Extending Linker Sequences between Antigen-Recognition Modules Provides More Effective Production of Bispecific Nanoantibodies in the Periplasma of E. coli

Bispecific Antibodies: From Research to Clinical Application

Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats

Understanding the structure-property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions

Discovery and investigation of the truncation of the (GGGGS)n linker and its effect on the productivity of bispecific antibodies expressed in mammalian cells

Structural basis for bispecific antibody design: arrangement of domain linkage produces activity enhancement

Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing

Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies

Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system